Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/1160
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWickramasinghe, Nilmini-
dc.contributor.otherAdibi, Sasan-
dc.contributor.otherNguyen, Lemai-
dc.contributor.otherHamper, Andreas-
dc.contributor.otherVogel, Douglas-
dc.contributor.otherBodendorf, Freimut-
dc.date.accessioned2017-07-19T01:52:07Z-
dc.date.available2017-07-19T01:52:07Z-
dc.date.issued2017-06-
dc.identifier.citationEpworth Research Institute Research Week 2017; Poster 54: pp 78en_US
dc.identifier.urihttp://hdl.handle.net/11434/1160-
dc.description.abstractINTRODUCTION/BACKGROUND: Globally, diabetes is at epidemic proportions and needs to be addressed. To date, there is no cure for diabetes and people with diabetes must self-manage this life-long condition. A central aspect of self-management is concerned with blood glucose monitoring. The dominant method for monitoring blood glucose levels is invasive; it typically requires a blood glucose meter, a lancet device plus test strips. Monitoring frequency depends on treatment type – people using insulin typically need to prick their finger 4-6 times a day or more. Finger-pricking has several disadvantages: a) Culturally, many people dislike using sharp objects and seeing blood; b) Psychologically, many people with diabetes report increased anxiety concerning finger-pricking, and the discomfort and inconvenience of the procedure; c) Clinically, there is a risk of infection and damage to the finger tissue. Further, finger-prick glucose monitoring is not designed to support continuous monitoring of blood glucose. Given that finger-prick monitoring devices provide only a snapshot of blood glucose at a specific time-point, many instances of hyperglycemia or hypoglycaemia may go undetected and unrecorded. Thus, the resultant monitoring outcomes may not fully represent the overall blood glucose pattern. METHOD: To design and develop a non-invasive blood glucose system using tera-hertz technology, we are following a design science research methodology> once the prototype is developed it will then be assessed for usability and fidelity in a clinical trial. RESULTS: To date, we have completed initial testing in the specialised lab to isolate the signatures for sugar in water solutions. The next phase is to test glucose in blood and then to develop the working prototype solution. CONCLUSIONS: There exists an important opportunity for a prudent, non-invasive technology solution to measure blood glucose which will be of significant benefit to individuals suffering from diabetes.en_US
dc.subjectTerahertzen_US
dc.subjectBody Area Networken_US
dc.subjectNon-invasive Blood Glucose Monitoringen_US
dc.subjectFinger-prickingen_US
dc.subjectDiabetesen_US
dc.subjectTBANen_US
dc.subjectDiabetes Self-Managementen_US
dc.subjectUsabilityen_US
dc.subjectCultural Factorsen_US
dc.subjectPsychological Factorsen_US
dc.subjectClinical Factorsen_US
dc.subjectHyperglycemiaen_US
dc.subjectHypoglycaemiaen_US
dc.subjectWorking Prototype Solutionen_US
dc.subjectTera-Hertz Technologyen_US
dc.subjectInitial Testingen_US
dc.subjectNon-Invasive Technology Solutionen_US
dc.subjectMeasuring Blood Glucoseen_US
dc.subjectChair of Health Informatics Management, Epworth HealthCare, Victoria, Australiaen_US
dc.titleTBAN – Terahertz Body Area Network for non-invasive blood glucose monitoring.en_US
dc.typeConference Posteren_US
dc.description.affiliatesDeakin Universityen_US
dc.description.affiliatesFAU University Erlangen-Nuremberg, Germanyen_US
dc.description.affiliatesHarbin Institute of Technology, Chinaen_US
dc.type.studyortrialValidation Studyen_US
dc.description.conferencenameEpworth Research Institute Research Week 2017en_US
dc.description.conferencelocationEpworth Research Institute, Victoria, Australiaen_US
dc.type.contenttypeTexten_US
Appears in Collections:Health Informatics
Internal Medicine
Research Month

Files in This Item:
There are no files associated with this item.


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.